Clinical Trials in Salt Lake City

Showing 2301-2320 of 14,325 trials

Study of Aspirin in Patients With Vestibular Schwannoma

NCT03079999

This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.

Vestibular SchwannomaAcoustic NeuromaNeurofibromatosis 2

Massachusetts Eye and Ear Infirmary97 participantsStarted Jun 2018

Stanford, California, United States • Miami, Florida, United States • Boston, Massachusetts, United States +2 more locations

Active Not RecruitingPhase 3< 1 mile

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

NCT04446117

This is a Phase 3, multi-center, randomized, open-label, controlled study designed to evaluate the safety and efficacy of cabozantinib given in combination with atezolizumab versus a second novel hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with one, and only one, NHT for their prostate cancer disease.

Metastatic Prostate CancerProstate Adenocarcinoma

Exelixis575 participantsStarted Oct 2020

Tucson, Arizona, United States • Duarte, California, United States • Fullerton, California, United States +277 more locations

Study of Aspirin in Patients With Vestibular Schwannoma

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Find Trials by Condition in Salt Lake City

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

SyncAV Post-Market Trial

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

The Johns Hopkins Heartburn Center Registry

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers